SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-193586
Filing Date
2019-07-15
Accepted
2019-07-15 07:22:04
Documents
3
Period of Report
2019-07-12
Items
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d772873d8k.htm 8-K 24545
2 EX-99.1 d772873dex991.htm EX-99.1 9500
3 GRAPHIC g772873g0714090734853.jpg GRAPHIC 2956
  Complete submission text file 0001193125-19-193586.txt   39712
Mailing Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 201S GAITHERSBURG MD 20878 2406541450
Altimmune, Inc. (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32587 | Film No.: 19954087
SIC: 2834 Pharmaceutical Preparations